Holen Sie sich die Stockscreener-App
61.35
3.17%
1.80
Handel nachbörslich:
61.35
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt DXCM?
Forum
Prognose
Aktiensplit
Dexcom Inc Aktie (DXCM) Neueste Nachrichten
DexCom Faces Potential Headwinds in 2026, but Expanding Reimbursement Offers Long-Term Prospects - Morningstar
DexCom Medicare Coverage NCD Remains Biggest 2026 Catalyst, RBC Says - marketscreener.com
JPMorgan Adjusts DexCom Price Target to $65 From $75 - marketscreener.com
DexCom, Inc. 2026 Q1ResultsEarnings Call Presentation (NASDAQ:DXCM) 2026-05-01 - Seeking Alpha
DexCom Stock Up on Q1 Earnings & Revenues Beat, Margins Rise - TradingView
DexCom, Inc. (NASDAQ:DXCM) Q1 2026 Earnings Call Transcript - Insider Monkey
Dexcom reports 15% YoY revenue uptick in Q1 yet maintains prior FY26 outlook - Yahoo Finance
DexCom Inc (NASDAQ:DXCM): A GARP Stock with Affordable Growth and Strong Fundamentals - ChartMill
Barclays Adjusts Price Target on DexCom to $67 From $72, Maintains Underweight Rating - marketscreener.com
Bernstein Adjusts Price Target on DexCom to $77 From $83, Maintains Outperform Rating - marketscreener.com
Bernstein SocGen lowers DexCom stock price target on valuation By Investing.com - Investing.com Canada
Raymond James Adjusts Price Target on DexCom to $81 From $83, Maintains Strong Buy Rating - marketscreener.com
Goldman Sachs Adjusts Price Target on DexCom to $80 From $82, Maintains Buy Rating - marketscreener.com
TD Cowen Adjusts Price Target on DexCom to $75 From $84, Maintains Buy Rating - marketscreener.com
HB Wealth Management LLC Cuts Stake in DexCom, Inc. $DXCM - MarketBeat
BTIG Remains Bullish on DexCom, Inc. (DXCM) - Insider Monkey
DexCom Inc (DXCM) Q1 2026 Earnings Call Highlights: Strong Reven - GuruFocus
DexCom Inc (DXCM) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and Strategic Market Expansions - GuruFocus
DexCom Q1 2026 slides: margin expansion accelerates, guidance raised By Investing.com - Investing.com South Africa
DexCom (DXCM) Reports Strong Q1 2026 Revenue Growth Driven by Pr - GuruFocus
Is It Too Late to Buy DexCom Inc (DXCM) After 3.5% Rally? GF Val - GuruFocus
Is DexCom (DXCM) 45.7% Undervalued After Q1 2026 Earnings Beat? - GuruFocus
DexCom (DXCM) Q1 2026 Earnings Transcript - The Motley Fool
DexCom Q1 Earnings Call Highlights - Yahoo Finance
Earnings call transcript: DexCom beats Q1 2026 forecasts, stock rises - Investing.com
Transcript : DexCom, Inc., Q1 2026 Earnings Call, Apr 30, 2026 - marketscreener.com
DexCom Q1 2026 Earnings Call Transcript - Benzinga
DexCom, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
DexCom (DXCM) Q1 Earnings and Revenues Top Estimates - Yahoo Finance Singapore
DexCom Inc. stock outperforms competitors on strong trading day - MarketWatch
Dexcom reaffirms full-year forecast after topping quarterly estimates - marketscreener.com
Dexcom shares fell as it reaffirms full-year outlook By Investing.com - Investing.com Canada
DexCom (NASDAQ:DXCM) Beats Q1 Earnings Forecasts, But Guidance and Revenue Miss Fuel After-Hours Drop - ChartMill
Dexcom falls over 5% despite better-than-expected Q1 print, as revenue guidance disappoints - Investing.com India
Q1 2026 Dexcom Inc Earnings Call Transcript - GuruFocus
DexCom Q1 Adjusted Earnings, Revenue Rise - marketscreener.com
DexCom (NASDAQ:DXCM) Exceeds Q1 CY2026 Expectations But Stock Drops - Yahoo Finance
Earnings Flash (DXCM) DexCom, Inc. Reports Q1 Revenue $1.19B, vs. FactSet Est of $1.17B - marketscreener.com
Earnings Flash (DXCM) DexCom, Inc. Posts Q1 Adjusted EPS $0.56 per Share, vs. FactSet Est of $0.47 - marketscreener.com
DexCom: Q1 Earnings Snapshot - marketscreener.com
[8-K] DEXCOM INC Reports Material Event - Stock Titan
Dexcom Reports First Quarter 2026 Financial Results - ChartMill
DexCom earnings ahead: Can margin gains offset growth concerns? By Investing.com - Investing.com India
DexCom earnings ahead: Can margin gains offset growth concerns? - Investing.com
Dexcom Inc. Stock (US2521311074): Q1 2026 Earnings Release Scheduled for April 30 - AD HOC NEWS
Is DexCom’s (DXCM) G7 Sensor Upgrade Quietly Redefining Its Core Recurring-Revenue Story? - simplywall.st
Vanguard Capital Management (NASDAQ: DXCM) reports 7.49% ownership - Stock Titan
DexCom Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Vanguard discloses 19.3M Dexcom shares as 5.02% holding (NASDAQ: DXCM) - Stock Titan
DexCom (DXCM) Q1 Earnings: What To Expect - Yahoo Finance
Why Medtech Giants Are Quietly Paying Up for AI Diagnostics - Benzinga
Why DexCom (DXCM) is a Top Value Stock for the Long-Term - Yahoo Finance
Vanguard Group Inc. Has $3.26 Billion Stock Holdings in DexCom, Inc. $DXCM - MarketBeat
A Look at DexCom Inc (DXCM) After 3.4% Decline -- GF Value $109. - GuruFocus
DexCom (DXCM) Q1 earnings: What to expect - MSN
DexCom Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Rick Osterloh Joins Dexcom’s Board of Directors - Medical Product Outsourcing
Is DexCom (DXCM) Now Fairly Priced After Recent Share Price Weakness? - Yahoo Finance
Dexcom gives sneak preview of CGM technologies’ long-term health benefits for diabetics - MSN
Listening to healthcare professionals: Dexcom launches new education offering, Dexcom Academy - MSN
DexCom, Inc. (DXCM) Stock Analysis: 41% Potential Upside Drives Investor Interest - DirectorsTalk Interviews
Is DexCom, Inc. (DXCM) A Good Stock To Buy Now? - Insider Monkey
0.46%
0.25%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):